S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/BVF Partners/Q1 2022

BVF Partners

Periodo: Q1 2022 Β· Depositato: 2022-05-16
Vedi su SEC EDGAR β†—
AUM
$2.50B
Valore totale del portafoglio
Posizioni
81
Titoli dichiarati
Prima Posizione
GHRS
6.8% $169.6M
Var. Trimestrali
+6 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2022-05-16) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
GHRSGH RESEARCH PLC$169.6M6.79%$18.29$27.01+47.7%
6.8%
KYMRKYMERA THERAPEUTICS INC$151.8M6.07%$42.32$113.51+168.2%
6.1%
RLAYRELAY THERAPEUTICS INC$135.6M5.42%$29.93$18.65-37.7%
5.4%
RCUSARCUS BIOSCIENCES INC$125.0M5.00%$31.56$30.33-3.9%
5.0%
MRUSMERUS N V$109.3M4.37%β€”β€”
4.4%
ARGXARGENX SE$99.7M3.99%$315.31$939.68+198.0%
4.0%
PTGXPROTAGONIST THERAPEUTICS INC$99.1M3.96%$23.68$131.62+455.8%
4.0%
XOMAXOMA CORP DEL$98.8M3.95%$27.98$43.00+53.7%
4.0%
RPTXREPARE THERAPEUTICS INC$83.4M3.34%β€”β€”
3.3%
ACRSACLARIS THERAPEUTICS INC$68.6M2.74%$17.24$5.56-67.8%
2.7%
CRNXCRINETICS PHARMACEUTICALS IN$65.9M2.64%$21.95$42.23+92.4%
2.6%
LKFTGALAPAGOS NV$64.9M2.60%$62.02$30.39-51.0%
2.6%
CGEMCULLINAN ONCOLOGY INC$56.2M2.25%$10.47$17.63+68.4%
2.3%
KURAKURA ONCOLOGY INC$51.5M2.06%$16.08$11.10-31.0%
2.1%
EQRXEQRX INC$49.7M1.99%β€”β€”
2.0%
XENEXENON PHARMACEUTICALS INC$48.9M1.95%$30.57$60.96+99.4%
1.9%
RVMDREVOLUTION MEDICINES INC$46.2M1.85%$25.51$189.24+641.8%
1.9%
ITOSITEOS THERAPEUTICS INC$45.1M1.80%β€”β€”
1.8%
RLMDRELMADA THERAPEUTICS INC$44.5M1.78%$26.99$6.28-76.7%
1.8%
CTICCTI BIOPHARMA CORP$41.7M1.67%β€”β€”
1.7%
SNDXSYNDAX PHARMACEUTICALS INC$41.6M1.66%$17.38$21.82+25.6%
1.7%
FDMT4D MOLECULAR THERAPEUTICS IN$40.3M1.61%$15.12$13.00-14.0%
1.6%
VRDNVIRIDIAN THERAPEUTICS INC$32.3M1.29%$18.49$19.40+4.9%
1.3%
OLMAOLEMA PHARMACEUTICALS INC$31.6M1.26%$4.26$12.64+196.7%
1.3%
CINCCINCOR PHARMA INC$30.4M1.22%β€”β€”
1.2%
LXRXLEXICON PHARMACEUTICALS INC$30.0M1.20%$2.09$2.32+11.0%
1.2%
ACIUAC IMMUNE SA$29.7M1.19%$4.00$2.51-37.3%
1.2%
STROSUTRO BIOPHARMA INC$28.3M1.13%$82.20$30.43-63.0%
1.1%
VSTMXXXXVERASTEM INC$28.2M1.13%β€”β€”
1.1%
PNTPOINT BIOPHARMA GLOBAL INC$26.8M1.07%β€”β€”
1.1%

AttivitΓ  Trimestre su Trimestre

Q1 2022 vs. Q4 2021

Nuove Posizioni (6)

TickerEmittenteNozionale
ITOSITEOS THERAPEUTICS INC$45.1M
CINCCINCOR PHARMA INC$30.4M
ANTXAN2 THERAPEUTICS INC$24.4M
IDYAIDEAYA BIOSCIENCES INC$17.9M
RDUSRADIUS HEALTH INC$3.3M
JNCEJOUNCE THERAPEUTICS INC$0.9M

Posizioni Chiuse (8)

TickerEmittenteNozionale
AMRNXXXXAMARIN CORP PLC$55.5M
KDNYCHINOOK THERAPEUTICS INC$29.4M
MIRMMIRUM PHARMACEUTICALS INC$7.0M
EUCRUEUCRATES BIOMEDICAL ACQU COR$5.0M
FLACUFRAZIER LIFESCIENCES ACQU CO$5.0M
FVAM5 01 ACQUISITION CORP$4.9M
RACBRESEARCH ALLIANCE CORP II$4.9M
JYACJIYA ACQUISITION CORP$2.9M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
VYGRVOYAGER THERAPEUTICS INC$9.0M+5256.3%
GBIOGENERATION BIO CO$19.2M+1382.7%
CNTACENTESSA PHARMACEUTICALS PLC$10.6M+286.2%
STROSUTRO BIOPHARMA INC$14.6M+272.7%-63.0%
ACRSACLARIS THERAPEUTICS INC$43.9M+134.5%-67.8%
ELDNELEDON PHARMACEUTICALS INC$3.1M+68.8%
PYXSPYXIS ONCOLOGY INC$-8.1M+59.8%
KURAKURA ONCOLOGY INC$22.6M+55.2%-31.0%

Ridotte (5)

TickerEmittenteNozionaleVar. AzioniDal Deposito
XENEXENON PHARMACEUTICALS INC$-53.9M-51.4%+99.4%
LKFTGALAPAGOS NV$1.1M-9.5%-51.0%
VRDNVIRIDIAN THERAPEUTICS INC$-4.9M-7.2%+4.9%
WHWKAADI BIOSCIENCE INC$-6.8M-2.3%
LXRXLEXICON PHARMACEUTICALS INC$-26.6M+0.0%+11.0%
← Torna agli Hedge Fund